Actively Recruiting
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
Led by Groupe Hospitalier du Havre · Updated on 2026-01-21
1000
Participants Needed
2
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. Investigators now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period. The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers. They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.
CONDITIONS
Official Title
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All fathers whose baby is 10 days old or less
You will not qualify if you...
- People with a poor understanding of spoken or written French
- Minors
- Persons under court protection, guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Antoine-Béclère hospital AP-HP
Clamart, France, 92140
Enrolling by Invitation
2
Le Havre hospital - site Jacques Monod
Montivilliers, France, 76290
Actively Recruiting
Research Team
A
Angélique PICARD, project coordinator
CONTACT
C
Christophe FRUIT, CRA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here